EZH2 and Hepatic fibrosis: As the transcription of EZH2 was impeded by Notch‐Hes1 signaling, blocking Notch facilitated fibrosis regression by strengthening EZH2‐regulated senescence, providing a promising therapeutic approach for the management of liver fibrosis.